Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.

Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease.

RECENT ANNOUNCEMENTS

Allotment and Distribution of New Options

Quarterly Report 31 December 2009

Change of Director's Interest Notice

 

UPDATE - Southern Cross Equities Analyst report on Biotron Dec 2009

2009 Annual Report

`